Old Drugs--new Uses

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 2007 Oct 16

PMID 17935601

Citations 36

Authors

J K Aronson

Affiliations

Soon will be listed here.

Citing Articles

Progress in treatment of pathological neuropathic pain after spinal cord injury.

Li J, Kang W, Wang X, Pan F Front Neurol. 2024; 15:1430288.

PMID: 39606699 PMC: 11600731. DOI: 10.3389/fneur.2024.1430288.

A Machine Learning Algorithm Suggests Repurposing Opportunities for Targeting Selected GPCRs.

El-Atawneh S, Goldblum A Int J Mol Sci. 2024; 25(18).

PMID: 39337714 PMC: 11432050. DOI: 10.3390/ijms251810230.

Drug Repurposing in the Chemotherapy of Infectious Diseases.

Hamid A, Maser P, Mahmoud A Molecules. 2024; 29(3).

PMID: 38338378 PMC: 10856722. DOI: 10.3390/molecules29030635.

AMMVF-DTI: A Novel Model Predicting Drug-Target Interactions Based on Attention Mechanism and Multi-View Fusion.

Wang L, Zhou Y, Chen Q Int J Mol Sci. 2023; 24(18).

PMID: 37762445 PMC: 10531525. DOI: 10.3390/ijms241814142.

Stereoselective Solvolysis in the Synthesis of Dorzolamide Intermediates.

Martinelli A, Volpicelli R, Verzini M, Cotarca L, Maini L, Pengo P ACS Omega. 2023; 8(31):28851-28858.

PMID: 37576669 PMC: 10413462. DOI: 10.1021/acsomega.3c03959.

References

Wang R, Li C, Song D, Zhao G, Zhao L, Jing Y . Ethacrynic acid butyl-ester induces apoptosis in leukemia cells through a hydrogen peroxide mediated pathway independent of glutathione S-transferase P1-1 inhibition. Cancer Res. 2007; 67(16):7856-64. DOI: 10.1158/0008-5472.CAN-07-0151. View

Thanacoody H . Thioridazine: resurrection as an antimicrobial agent?. Br J Clin Pharmacol. 2007; 64(5):566-74. PMC: 2203271. DOI: 10.1111/j.1365-2125.2007.03021.x. View

Chan A, Ogino S, Fuchs C . Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med. 2007; 356(21):2131-42. DOI: 10.1056/NEJMoa067208. View

Clive S, Gardiner J, Leonard R . Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma. Cancer Chemother Pharmacol. 1999; 44 Suppl:S29-30. DOI: 10.1007/s002800051114. View

. The "liquid cosh" libel. Br Med J (Clin Res Ed). 1983; 286(6359):153. PMC: 1546377. View

Flugelman M, Tal A, Pollack S, Hefez A, Weisstub E, Gotsman M . Psychotropic drugs and long QT syndromes: case reports. J Clin Psychiatry. 1985; 46(7):290-1. View

Basu M, Duckett J . Detrusor overactivity successfully treated with duloxetine. J Obstet Gynaecol. 2007; 27(4):438-40. DOI: 10.1080/01443610701359621. View

Sundar S, Rosenkaimer F, Makharia M, Goyal A, Mandal A, Voss A . Trial of oral miltefosine for visceral leishmaniasis. Lancet. 1998; 352(9143):1821-3. DOI: 10.1016/S0140-6736(98)04367-0. View

Gensini G, Conti A, Lippi D . The contributions of Paul Ehrlich to infectious disease. J Infect. 2006; 54(3):221-4. DOI: 10.1016/j.jinf.2004.05.022. View

10.

Kemper A, Dunlap R, Pietro D . Thioridazine-induced torsade de pointes. Successful therapy with isoproterenol. JAMA. 1983; 249(21):2931-4. View

11.

Courvoisier S, FOURNEL J, DUCROT R, KOLSKY M, KOETSCHET P . [Pharmacodynamic properties of 3-chloro-10-(3-dimethylaminopropyl)-phenothiazine hydrochloride (R.P. 4560); experimental study of a new substance used in potentialized anesthesia and in artificial hibernation]. Arch Int Pharmacodyn Ther. 1953; 92(3-4):305-61. View

12.

Villahermosa L, Fajardo Jr T, Abalos R, Balagon M, Tan E, Cellona R . A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum. Am J Trop Med Hyg. 2005; 72(5):518-26. View

13.

Aronson J . Drug development: more science, more education. Br J Clin Pharmacol. 2005; 59(4):377-8. PMC: 1884815. DOI: 10.1111/j.0306-5251.2005.02420.x. View

14.

Gillis J, Goa K . Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia. Drugs. 1995; 50(5):897-923. DOI: 10.2165/00003495-199550050-00008. View

15.

Zamanian R, Haddad F, Doyle R, Weinacker A . Management strategies for patients with pulmonary hypertension in the intensive care unit. Crit Care Med. 2007; 35(9):2037-50. DOI: 10.1097/01.ccm.0000280433.74246.9e. View

16.

Chong C, Sullivan Jr D . New uses for old drugs. Nature. 2007; 448(7154):645-6. DOI: 10.1038/448645a. View

17.

Durk H . Maintenance therapy for multiple myeloma with particular emphasis on thalidomide. Onkologie. 2007; 29(12):582-90. DOI: 10.1159/000096262. View

18.

Jurcic J, Soignet S, Maslak A . Diagnosis and treatment of acute promyelocytic leukemia. Curr Oncol Rep. 2007; 9(5):337-44. DOI: 10.1007/s11912-007-0045-9. View

19.

DiMasi J, Hansen R, Grabowski H . The price of innovation: new estimates of drug development costs. J Health Econ. 2003; 22(2):151-85. DOI: 10.1016/S0167-6296(02)00126-1. View

20.

Reilly J, Ayis S, Ferrier I, Jones S, Thomas S . QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet. 2000; 355(9209):1048-52. DOI: 10.1016/s0140-6736(00)02035-3. View